美国Zyomyx Inc  
Zyomyx公司将可以成为提供高品质生物芯片的领导者，Zyomyx公司的客户可以得到更快速、更有效率的服务，使用少量样品就可以开发出用于治疗与诊断的产品。

Zyomyx Inc. is an innovator and leader in the development and commercialization of proprietary protein analysis platforms, with 8+ years of product development experience in protein biochips and biointerface technologies. With varied technology assets and a proven R&D core expertise in biochemistry, materials science and microsystem technologies, Zyomyx is entering development agreements primarily aimed at providing its clients with marketable products and technologies. In addition, Zyomyx offers its existing product line of protein profiling bioassays to new and existing customers through a streamlined service model.

Since its founding in 1998, Zyomyx has also been pursuing an aggressive intellectual property strategy. The rich portfolio of more than 120 pending and issued patents is constantly being expanded and also provides a broad platform enabling our development partners to market and protect their products as well as to develop new products in cooperation with Zyomyx.

Zyomyx has an extended knowledge base focused on areas including proteomics, molecular diagnostics, medical devices and industrial applications where the company's unique surface science and biointerface capabilities are key elements in next generation products. The infrastructure at Zyomyx includes state-of-the-art R&D facilities, a sophisticated analytical instrumentation suite as well as a fully operational biochip manufacturing line.